{
  "id": 18176456,
  "title": "Kamau shares first data from revamped sickle cell gene editing therapy",
  "url": "https://urgent.news/2026/11/04/kamau-shares-first-data-from-revamped-sickle-cell-gene-editing-therapy",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-04T20:05:28.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/kamau-shares-first-data-from-revamped-sickle-cell-gene-editing-therapy/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Kamau Therapeutics, which has stayed relatively quiet since its 2023 emergence, is sharing clinical data from its revamped sickle cell gene editing program for the first time. The startup is giving a ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "GEN Biotechnology",
        "title": "Kamau Therapeutics Releases Encouraging Sickle Cell Clinical Data Ahead of ASH Meeting",
        "url": "https://urgent.news/2026/11/04/kamau-therapeutics-releases-encouraging-sickle-cell-clinical-data",
        "published": "2026-11-04T14:19:47.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}